If anyone missed it they don’t read the filings.
Post# of 36537
(Total Views: 446)
Posted On: 03/05/2019 9:41:30 PM
Re: sademployee #2621
If anyone missed it they don’t read the filings.
“Material Adverse Effect” or “Material Adverse Change” means any effect or change that would be materially adverse to the Assets; provided, however, that the foregoing will not include any event, effect, circumstance, change, occurrence, fact or development resulting from or relating to (i) general business or economic conditions, (ii) national or international political or social conditions, including the engagement by the United States of America in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon the United States of America or any of its territories, possessions or diplomatic or consular offices or upon any military installation, equipment or personnel of the United States of America, (iii) financial, banking or securities markets (including any disruption thereof and any decline in the price of any security or any market index), (iv) changes in GAAP, (v) changes in Law other than Health Care Law, except to the extent that any of the events, effects, circumstances, changes, occurrences, facts or developments in the foregoing clauses (i) through (v) has had a disproportionate effect on the Seller as compared to other participants in the industry in which the Seller operates, (vi) the negotiation, execution, or delivery of this Agreement or the announcement or consummation of any of the transactions contemplated hereby, (vii) the Medoc Federal Investigation described in Disclosure Schedule 4.11, or (viii) any fact or circumstance arising after a Closing with respect to the Assets transferred during the Closing.”
“”Excluded Subsidiaries” means Medoc Health Services, L.L.C., Total Rx Care, LLC, Forman Pharmacy Management, LLC, Smile Pharmaceutical, Inc., Luna Pharmacy Management, LLC, Pure Pharmacy, LLC, Groth Pharmacy Management, LLC, Pharmacare Texas, Inc. and any entity which has been formed by the Seller but does not conduct any Business operations or own any of the Assets at the time of Closing.”
Medoc excluded.
https://www.streetinsider.com/dr/news.php?id=14686416
Veneto revs we know:
https://www.sec.gov/Archives/edgar/data/10597...ex99_3.htm
Until Gnbt files a quarterly that includes a time period of actually owning Veneto.
None of the executive team collect cash salary at this time or bod. Showing faith there, that’s good not bad, as are ceo and three other principals pooling their dividends together for use by company to make acquisitions.
Read the cc from a month ago for questioning and answering (questions by me to Gnbt ceo and Olaregen) about Excellagen prior history and how it’s to be more successful this time, contrasts etc.
Excellagen cpt codes
https://static1.squarespace.com/static/5b7c63...283%29.pdf
One of my best friends passed away today so you can find that on your time. Or ask info at Gnbt for a transcript.
“Material Adverse Effect” or “Material Adverse Change” means any effect or change that would be materially adverse to the Assets; provided, however, that the foregoing will not include any event, effect, circumstance, change, occurrence, fact or development resulting from or relating to (i) general business or economic conditions, (ii) national or international political or social conditions, including the engagement by the United States of America in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon the United States of America or any of its territories, possessions or diplomatic or consular offices or upon any military installation, equipment or personnel of the United States of America, (iii) financial, banking or securities markets (including any disruption thereof and any decline in the price of any security or any market index), (iv) changes in GAAP, (v) changes in Law other than Health Care Law, except to the extent that any of the events, effects, circumstances, changes, occurrences, facts or developments in the foregoing clauses (i) through (v) has had a disproportionate effect on the Seller as compared to other participants in the industry in which the Seller operates, (vi) the negotiation, execution, or delivery of this Agreement or the announcement or consummation of any of the transactions contemplated hereby, (vii) the Medoc Federal Investigation described in Disclosure Schedule 4.11, or (viii) any fact or circumstance arising after a Closing with respect to the Assets transferred during the Closing.”
“”Excluded Subsidiaries” means Medoc Health Services, L.L.C., Total Rx Care, LLC, Forman Pharmacy Management, LLC, Smile Pharmaceutical, Inc., Luna Pharmacy Management, LLC, Pure Pharmacy, LLC, Groth Pharmacy Management, LLC, Pharmacare Texas, Inc. and any entity which has been formed by the Seller but does not conduct any Business operations or own any of the Assets at the time of Closing.”
Medoc excluded.
https://www.streetinsider.com/dr/news.php?id=14686416
Veneto revs we know:
https://www.sec.gov/Archives/edgar/data/10597...ex99_3.htm
Until Gnbt files a quarterly that includes a time period of actually owning Veneto.
None of the executive team collect cash salary at this time or bod. Showing faith there, that’s good not bad, as are ceo and three other principals pooling their dividends together for use by company to make acquisitions.
Read the cc from a month ago for questioning and answering (questions by me to Gnbt ceo and Olaregen) about Excellagen prior history and how it’s to be more successful this time, contrasts etc.
Excellagen cpt codes
https://static1.squarespace.com/static/5b7c63...283%29.pdf
One of my best friends passed away today so you can find that on your time. Or ask info at Gnbt for a transcript.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼